Is the generic version of pemetinib produced by Daewong Pharmaceutical or Lucius?

Pemigatinib (Pemigatinib) is a targeted drug used to treat cholangiocarcinoma and other tumors. It is currently marketed in China in the form of pemetinib tablets. The drug has not yet been included in medical insurance. The main specifications on the domestic market are 4.5mg 14 tablets and 9mg 14 tablets. The price range is roughly 2 to 5 RMB per box. Due to higher prices, some patients and medical institutions are concerned about the source and quality of generic drugs.

Regarding the generic drug manufacturer of pemetinib, the most common version on the market is the version produced by Lucius Pharma of Laos (Lucius Pharma). The price of the 4.5mg*14 generic drugs produced by this factory is very affordable, with each box selling for only about RMB 700 (the specific price is affected by the exchange rate and market supply and demand). Lucius Pharmaceuticals has become an alternative chosen by many overseas patients and some domestic patients because of its stable product quality and relatively low prices.

There is currently no authoritative public information showing that Da Xiong Pharmaceutical (Da Xiong Pharmaceutical) is involved in the production of generic pemetinib. The major generic drug manufacturer generally recognized in the industry is Lucius Pharmaceuticals. Especially in Southeast Asia and some overseas markets, Lucius's generic pemetinib has relatively active sales and is widely used. Patients need to pay attention to the source of drugs when purchasing, ensure that they obtain drugs through formal channels, and ensure drug safety.

To sum up, the generic version of pemetinib is mainly produced by Lucius Pharmaceuticals of Laos, not Daxiong Pharmaceuticals. Patients may face purchase difficulties due to price and medical insurance restrictions in China. They may consider overseas versions of Lucius Pharmaceuticals as an alternative. However, they should strictly verify the authenticity and quality of the drugs and consult with doctors to formulate a reasonable medication plan to ensure treatment effectiveness and safety.

Reference: https://go.drugbank.com/drugs/